Champions Oncolog
(CSBR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 01-2002 | 10-2001 | 07-2001 | 04-2001 | 01-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 283 | 359 | 438 | 452 | 434 |
| Receivables | 0 | 0 | N/A | 1 | 4 |
| Inventories | 23 | 20 | 15 | 25 | 52 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 208 |
| TOTAL | $321 | $393 | $475 | $495 | $713 |
| Non-Current Assets | |||||
| PPE Net | 291 | 296 | 308 | 320 | 340 |
| Investments And Advances | 50 | 50 | 50 | 50 | 50 |
| Other Non-Current Assets | 11 | 11 | 11 | 11 | 11 |
| TOTAL | $352 | $357 | $369 | $381 | $401 |
| Total Assets | $673 | $750 | $844 | $876 | $1,114 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 60 | 102 | 122 | 126 | 12 |
| TOTAL | $625 | $619 | $716 | $712 | $714 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 4 | 4 | 69 | 69 | 104 |
| TOTAL | $8 | $11 | $11 | $14 | $19 |
| Total Liabilities | $633 | $630 | $727 | $725 | $732 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 709 | 709 | 709 | 709 | 709 |
| Common Shares | 9 | 9 | 9 | 9 | 9 |
| Retained earnings | -5,858 | -5,757 | -5,760 | -5,726 | -5,496 |
| Other shareholders' equity | 531 | 531 | 531 | 531 | 531 |
| TOTAL | $39 | $120 | $117 | $151 | $382 |
| Total Liabilities And Equity | $673 | $750 | $844 | $876 | $1,114 |